GLAC BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.12 TWD | +0.05% |
|
+0.14% | -.--% |
| 2019 | Glac Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
| 2017 | Glac Biotech Co., Ltd. completed the acquisition of Glory Biotech Co., Ltd.. | CI |
| Sales 2017 | 797M 24.7M | Sales 2018 | 989M 30.64M | Capitalization | 2.38B 73.77M |
|---|---|---|---|---|---|
| Net income 2017 | 51M 1.58M | Net income 2018 | 95M 2.94M | EV / Sales 2017 | 1.37 x |
| Net cash position 2017 | 784M 24.3M | Net cash position 2018 | 518M 16.04M | EV / Sales 2018 | 1.88 x |
| P/E ratio 2017 |
42.3
x | P/E ratio 2018 |
25
x | Employees | - |
| Yield 2017 |
10% | Yield 2018 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
| 1 day | +0.05% |
| Managers | Title | Age | Since |
|---|---|---|---|
Chung Wei Kuo
CEO | Chief Executive Officer | - | 08-08-04 |
Sheng Hung Huang
DFI | Director of Finance/CFO | - | 14-07-06 |
Pei Shan Hsieh
CTO | Chief Tech/Sci/R&D Officer | - | 08-08-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wan Lai Cheng
BRD | Director/Board Member | - | 08-07-29 |
Chung Liang Li
BRD | Director/Board Member | 71 | - |
Jung Chin Lin
CHM | Chairman | 70 | 08-07-20 |
Glac Biotech Co Ltd is a Taiwan-based company principally engaged in research and development, manufacturing and sale of probiotics- and fermentation-related application products. The Company manufactures microencapsulated functional probiotic powder, leavening agents, as well as application products such as fermented concentrated solution and others. Its products are applied in medicine, health food, food, animal husbandry and other areas. The Company mainly distributes its products to Mainland China, Taiwan and other markets.
Sector
-
- Stock Market
- Equities
- 6553 Stock
